• CONTACT US: +92 51 8738362-5
  • EMAIL: [email protected]
  • ABOUT US
    • CORPORATE HISTORY –
    • BUSINESS PARTNERSHIPS –
    • QUALITY CONTROL & QUALITY ASSURANCE –
    • MANUFACTURING EXPERTISE –
    • MARKETING & SALES –
  • OUR DIVISIONS
    • PHARMA HEALTH DIVISION –
    • ANIMAL HEALTH DIVISION –
    • BIO-LABS CONSUMER HEALTH
  • PRODUCTS
    • ALL FEATURED BRANDS
    • PHARMA HEALTH PRODUCTS LIST
    • ANIMAL HEALTH PRODUCTS LIST
  • GLOBAL PRESENCE –
  • BIO-LABS SUBSIDIARIES –
    • Bio-Next Pharmaceuticals –
    • Bio-Labs Consumer Health –
    • ZH Therapeutics –
  • CSR –
  • NEWS & PRESS –
  • CAREERS –
  • CONTACT
0
  • Home
  • News
  • Bio-Labs received the “Leading Pandemic Healthcare & Pharmaceutical Company Award”
Bio-Labs Signed Several MOUs with Leading Sri Lankan Pharmaceutical Entities for Joint Ventures
November 23, 2021
MOLNUCAP Capsules (Molnupiravir) breakthrough new drug for COVID-19
December 15, 2021
November 23, 2021

Bio-Labs received the “Leading Pandemic Healthcare & Pharmaceutical Company Award” in recognition of the provision of breakthrough therapies during the COVID-19 pandemic at the RCCI 33rd International Achievement Awards 2021 held in Colombo, Sri Lanka in November, 2021. This award was presented by the Honorable Prime Minister of Sri Lanka, H.E. Mahinda Rajapaksa.

Bio-labs’ Rivona (Remdesivir) is the most successful antiviral drug for the treatment of COVID-19 not only in Pakistan but globally.

Share

Related posts

June 14, 2022

Bio-Labs Signed MOU with N-ovative Health Technologies (NHT), for cardiac stents & catheters


Read more
June 7, 2022

Bio-Labs – Donated medicines to Sri Lanka


Read more
February 14, 2022

Bio-Labs successfully launched Qualey (Quetiapine Fumarate) in it’s Psychiatry Division


Read more

 

Bio-Labs is an innovative healthcare company expert in manufacturing and quality control of high-end pharmaceutical products.

  • Contact US: +92 51 8738362-5
  • EMAIL: [email protected]
  • ADDRESS: ISLAMABAD, PAKISTAN

QUICK LINKS

  • HOME
  • CORPORATE HISTORY
  • PHARMA HEALTH DIVISION
  • ANIMAL HEALTH DIVISION
  • PRODUCTS
  • NEWS & PRESS
  • CAREERS
  • CONTACT

RECENT POST

  • 0
    Bio-Labs Signed MOU with N-ovative Health Technologies (NHT), for cardiac stents & catheters
    June 14, 2022
  • 0
    Bio-Labs – Donated medicines to Sri Lanka
    June 7, 2022
  • 0
    Bio-Labs successfully launched Qualey (Quetiapine Fumarate) in it’s Psychiatry Division
    February 14, 2022

BIO-LABS SISTER CONCERNS

  • Bio-Next Pharmaceuticals
  • Bio-Labs Consumer Health
  • ZHTherapeutics
Copyrights © 2022 Bio-Labs | All rights reserved.